Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vari

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Transplantation Proceedings|December 5, 1998
The suppression of heart and liver allograft rejection by liver suppressor factor one (LSF-1) and its possible human homologueS Goto, R Lord, Y Shimizu, et al.
Clinical and Experimental Immunology|October 1, 2015
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphomaK Jones, L Wockner, R M Brennan, et al.
Blood|November 17, 2020
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entityM K Gandhi, T Hoang, S C Law, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Transplantation Proceedings|December 5, 1998
The suppression of heart and liver allograft rejection by liver suppressor factor one (LSF-1) and its possible human homologueS Goto, R Lord, Y Shimizu, et al.
Clinical and Experimental Immunology|October 1, 2015
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphomaK Jones, L Wockner, R M Brennan, et al.
Blood|November 17, 2020
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entityM K Gandhi, T Hoang, S C Law, et al.
Pageof 3